معرفی
Professor Willie Hamilton is Professor of Primary Care Diagnostics at the University of Exeter's Health and Community Sciences school. A third-generation Belfast doctor, he specializes in primary care cancer diagnostics with transformative impact on UK cancer diagnosis pathways. As clinical lead for NICE's 'Referral for Suspected Cancer' guideline (NG12, 2015), his work underpins 100 of 210 recommendations governing £1 billion in annual NHS spending, contributing to reduced avoidable cancer deaths and improved survival rates through earlier diagnosis.
His educational background includes:
- BSc in Medical Microbiology (Bristol, 1979)
- MB, ChB (Bristol, 1982)
- MRCP (UK, 1986)
- MRCGP (1989)
- FRCGP (2002)
- FRCP (2003)
- MD thesis: 'Earlier diagnosis of colorectal, lung and prostate cancer' (Bristol, 2005)
Hamilton's research centers on developing and validating cancer risk assessment tools for primary care, generating electronic clinical decision support systems used in UK GP surgeries to estimate cancer risk from patient symptoms. His DISCOVERY unit (DIagnosing Symptomatic Cancer Optimally) focuses on optimizing diagnostic pathways across multiple cancers, with recent work expanding into dementia diagnostics (DECODE Project) and musculoskeletal disorders while maintaining cancer diagnosis as the core theme. His profoundly deaf status has not impeded his career, guided by the mantra 'Deaf people can do anything except hear' alongside professional mottos 'Quaerere Verum' and 'Cum Scientia Caritas'.
Analysis of his recent publications reveals concentrated efforts on optimizing colorectal cancer diagnosis through faecal immunochemical testing (FIT), with growing emphasis on health equity, patient/practitioner perspectives, and cost-effectiveness. His work spans ovarian, lung, and multi-cancer detection, increasingly incorporating AI techniques and electronic decision support while addressing socioeconomic disparities in diagnostic access and outcomes.
His notable recognition includes:
- CBE for services in improving early cancer diagnosis (2019 New Year Honours)
- RCGP Overall Paper of the Year (awarded twice)
Hamilton leads fifteen research staff and PhD students while securing over £30 million in competitive funding, including:
- NIHR programme grants (2010-2016, 2020)
- Department of Health Policy Research Unit (£5 million, 2010-2018, renewed 2019)
- Cancer Research UK Catalyst award (£4.83 million, 2015-2020)
- Dennis and Mireille Gillings Foundation donation (£2 million for ERICA trial)
He directs the DISCOVERY unit at Exeter Medical School and co-leads the international CanTest collaboration, focusing on optimizing cancer diagnosis through integrated risk tools, clinical trials, and policy implementation while mentoring the next generation of diagnostic researchers.
